Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 14
1993 38
1994 74
1995 51
1996 68
1997 47
1998 39
1999 54
2000 42
2001 44
2002 51
2003 38
2004 54
2005 35
2006 41
2007 32
2008 29
2009 47
2010 57
2011 61
2012 42
2013 40
2014 39
2015 39
2016 29
2017 43
2018 48
2019 41
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

1,146 results
Results by year
Filters applied: . Clear all
Page 1
Cladribine: mechanisms and mysteries in multiple sclerosis.
Jacobs BM, Ammoscato F, Giovannoni G, Baker D, Schmierer K. Jacobs BM, et al. J Neurol Neurosurg Psychiatry. 2018 Dec;89(12):1266-1271. doi: 10.1136/jnnp-2017-317411. Epub 2018 Jul 10. J Neurol Neurosurg Psychiatry. 2018. PMID: 29991490 Review.
Cladribine Tablets: A Review in Relapsing MS.
Deeks ED. Deeks ED. CNS Drugs. 2018 Aug;32(8):785-796. doi: 10.1007/s40263-018-0562-0. CNS Drugs. 2018. PMID: 30105527 Free PMC article. Review.
Cladribine to Treat Relapsing Forms of Multiple Sclerosis.
Giovannoni G. Giovannoni G. Neurotherapeutics. 2017 Oct;14(4):874-887. doi: 10.1007/s13311-017-0573-4. Neurotherapeutics. 2017. PMID: 29168160 Free PMC article. Review.
An update on cladribine for relapsing-remitting multiple sclerosis.
Holmøy T, Torkildsen Ø, Myhr KM. Holmøy T, et al. Expert Opin Pharmacother. 2017 Oct;18(15):1627-1635. doi: 10.1080/14656566.2017.1372747. Epub 2017 Sep 11. Expert Opin Pharmacother. 2017. PMID: 28858531 Review.
Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study.
Giovannoni G, Soelberg Sorensen P, Cook S, Rammohan K, Rieckmann P, Comi G, Dangond F, Adeniji AK, Vermersch P. Giovannoni G, et al. Mult Scler. 2018 Oct;24(12):1594-1604. doi: 10.1177/1352458517727603. Epub 2017 Sep 5. Mult Scler. 2018. PMID: 28870107 Free article. Clinical Trial.
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.
Grever MR, Abdel-Wahab O, Andritsos LA, Banerji V, Barrientos J, Blachly JS, Call TG, Catovsky D, Dearden C, Demeter J, Else M, Forconi F, Gozzetti A, Ho AD, Johnston JB, Jones J, Juliusson G, Kraut E, Kreitman RJ, Larratt L, Lauria F, Lozanski G, Montserrat E, Parikh SA, Park JH, Polliack A, Quest GR, Rai KR, Ravandi F, Robak T, Saven A, Seymour JF, Tadmor T, Tallman MS, Tam C, Tiacci E, Troussard X, Zent CS, Zenz T, Zinzani PL, Falini B. Grever MR, et al. Blood. 2017 Feb 2;129(5):553-560. doi: 10.1182/blood-2016-01-689422. Epub 2016 Nov 30. Blood. 2017. PMID: 27903528 Free PMC article.
Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis.
Comi G, Cook S, Giovannoni G, Rieckmann P, Sørensen PS, Vermersch P, Galazka A, Nolting A, Hicking C, Dangond F. Comi G, et al. Mult Scler Relat Disord. 2019 Apr;29:168-174. doi: 10.1016/j.msard.2019.01.038. Epub 2019 Jan 24. Mult Scler Relat Disord. 2019. PMID: 30885375 Free article.
[Cladribine in the treatment of relapsing multiple sclerosis].
Robles-Cedeno R, Ramio-Torrenta L. Robles-Cedeno R, et al. Rev Neurol. 2018 Nov 1;67(9):343-354. Rev Neurol. 2018. PMID: 30350846 Free article. Review. Spanish.
1,146 results
Jump to page
Feedback